Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
-
31st Dec 16 Source: CRO
- €19 million turnover
-
€3.5 million
profit - 73 employees
- 2 more years available »
Ranking
By Turnover
(€18.7 million)- 902nd in Top Companies
- 97th in Health
By Employees
(69)- 792nd in Top Companies
- 91st in Health
- 69
- €18.7 million
Employees
- John Eskdale Country Manager
Latest News
- Jan 26 Greencore to prove update on business after US exit
- Jan 26 NI house builder apologises to Harry and Meghan over adverts
- Jan 26 US threatens retaliation against EU over proposed carbon tax
- Jan 26 Volvo warns of scaled back car line-up if UK splits from EU rules
- Jan 26 CPL founders Anne Heraty and Paul Carroll in line for €1m dividend payout